"epidermal growth factor" trang 11 - tải miễn phí từ tailieunhanh
Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients

Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients
8    51    1
MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway

MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway
13    54    1
Role of LPAR3, PKC and EGFR in LPA-induced cell migration in oral squamous carcinoma cells

Role of LPAR3, PKC and EGFR in LPA-induced cell migration in oral squamous carcinoma cells
16    48    1
Simultaneous identification of 36 mutations in KRAS codons 61and 146, BRAF, NRAS, and PIK3CA in a single reaction by multiplex assay kit

Simultaneous identification of 36 mutations in KRAS codons 61and 146, BRAF, NRAS, and PIK3CA in a single reaction by multiplex assay kit
9    54    1
Circulating tumor cells in HER2-positive metastatic breast cancer patients: A valuable prognostic and predictive biomarker

Circulating tumor cells in HER2-positive metastatic breast cancer patients: A valuable prognostic and predictive biomarker
8    52    1
Analytic performance studies and clinical reproducibility of a real-time PCR assay for the detection of epidermal growth factor receptor gene mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer

Analytic performance studies and clinical reproducibility of a real-time PCR assay for the detection of epidermal growth factor receptor gene mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer
10    51    1
Alterations of the genes involved in the PI3K and estrogen-receptor pathways influence outcome in human epidermal growth factor receptor 2-positive and hormone receptor-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy

Alterations of the genes involved in the PI3K and estrogen-receptor pathways influence outcome in human epidermal growth factor receptor 2-positive and hormone receptor-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy
16    28    1
OSU-03012 sensitizes breast cancers to lapatinib-induced cell killing: A role for Nck1 but not Nck2

OSU-03012 sensitizes breast cancers to lapatinib-induced cell killing: A role for Nck1 but not Nck2
11    31    1
Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFR mutation

Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFR mutation
5    36    1
Heparan sulfate mediates trastuzumab effect in breast cancer cells

Heparan sulfate mediates trastuzumab effect in breast cancer cells
13    32    1
Capecitabine and bevacizumab for non-resectable metastatic colorectal cancer patients: Final results from phase II AIO KRK 0105 trial

Capecitabine and bevacizumab for non-resectable metastatic colorectal cancer patients: Final results from phase II AIO KRK 0105 trial
7    46    1
Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies

Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies
11    29    1
Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: Interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes

Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: Interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes
12    44    1
Detection and characterization of classical and “uncommon” exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencing

Detection and characterization of classical and “uncommon” exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencing
9    52    1
TRAIL and proteasome inhibitors combination induces a robust apoptosis in human malignant pleural mesothelioma cells through Mcl-1 and Akt protein cleavages

TRAIL and proteasome inhibitors combination induces a robust apoptosis in human malignant pleural mesothelioma cells through Mcl-1 and Akt protein cleavages
10    69    1
A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene

A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene
4    53    1
Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs

Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs
12    51    1
Alterations in epidermal growth factor receptors 1 and 2 in esophageal squamous cell carcinomas

Alterations in epidermal growth factor receptors 1 and 2 in esophageal squamous cell carcinomas
10    54    1
Allelotypes of lung adenocarcinomas featuring ALK fusion demonstrate fewer onco- and suppressor gene changes

Allelotypes of lung adenocarcinomas featuring ALK fusion demonstrate fewer onco- and suppressor gene changes
10    38    1
Prediction of sensitivity to gefitinib/ erlotinib for EGFR mutations in NSCLC based on structural interaction fingerprints and multilinear principal component analysis

Prediction of sensitivity to gefitinib/ erlotinib for EGFR mutations in NSCLC based on structural interaction fingerprints and multilinear principal component analysis
13    44    1